Your browser doesn't support javascript.
loading
Efficacy and safety of apremilast in patients with moderate-to-severe genital psoriasis: Results from DISCREET, a phase 3 randomized, double-blind, placebo-controlled trial.
Merola, Joseph F; Parish, Lawrence Charles; Guenther, Lyn; Lynde, Charles; Lacour, Jean-Philippe; Staubach, Petra; Cheng, Sue; Paris, Maria; Picard, Hernan; Deignan, Cynthia; Jardon, Shauna; Chen, Mindy; Papp, Kim A.
Afiliación
  • Merola JF; Division of Rheumatology, Department of Dermatology and Department of Medicine and Associate Program Director, Combined Medicine-Dermatology Residency Program, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: joseph.merola@gmail.com.
  • Parish LC; President, Paddington Testing Company, Inc, Philadelphia, Pennsylvania.
  • Guenther L; Guenther Research Inc, London, Ontario, Canada.
  • Lynde C; Chief Medical Director, Lynde Institute for Dermatology, Markham, Ontario, Canada; Probity Medical Research, Markham, Ontario, Canada.
  • Lacour JP; Department of Dermatology, CHU de Nice - Hôpital l'Archet, Nice, France.
  • Staubach P; Department of Dermatology, University Medical Center, Mainz, Germany.
  • Cheng S; Global Development, Amgen Inc, Thousand Oaks, California.
  • Paris M; Global Patient Safety, Amgen Inc, Thousand Oaks, California.
  • Picard H; Global Development, Amgen Inc, Thousand Oaks, California.
  • Deignan C; Medical Affairs, Amgen Inc, Thousand Oaks, California.
  • Jardon S; Medical Affairs, Amgen Inc, Thousand Oaks, California.
  • Chen M; Global Development, Amgen Inc, Thousand Oaks, California.
  • Papp KA; Alliance Clinical Trials and Probity Medical Research, Waterloo, Ontario, Canada; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
J Am Acad Dermatol ; 90(3): 485-493, 2024 Mar.
Article en En | MEDLINE | ID: mdl-37852306

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Psoriasis / Calidad de Vida / Talidomida Límite: Humans Idioma: En Revista: J Am Acad Dermatol Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Psoriasis / Calidad de Vida / Talidomida Límite: Humans Idioma: En Revista: J Am Acad Dermatol Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos